As blood biomarkers have been shown to be associated with the development of sarcopenia, this study will measure common blood biomarkers of IL-6, TNF-α, CRP, GH, IGF-1, and MSTN and FST as outcome measures. This evidence concerns the gene GH1 and sarcopenia.